Showing results (1741-1750 of 2,232) with videos related to
Sort By:
Pageof 224
JTO Clinical and Research Reports|August 11, 2025
Phase 3 Trials of Neoadjuvant, Perioperative, and Adjuvant Chemoimmunotherapy for Resectable, Early-Stage NSCLC: Comprehensive Review and Detailed AnalysisJay M Lee, Alessandro Brunelli, Amy L Cummings, et al.Angewandte Chemie (International Ed. in English)|January 4, 2025
Secupyritines A-C, Three Natural Propellane Securinega Alkaloids: Structure Elucidation and Total Synthesis Based on Biogenetic Building BlocksGuan-Qiu Qin, Gui-Yang Wang, Qin-Cheng Shen, et al.Angewandte Chemie (International Ed. in English)|April 20, 2026
Schottky-Orbital Coupling Drives Ion-Electron Transfer: Triggering Stable Fast-Charging in MnV-Based Phosphate CathodeMiao Du, Ze-Lin Hao, Jia-Lin Yang, et al.Cancer Letters|June 24, 2017
EGFR T790M ctDNA testing platforms and their role as companion diagnostics: Correlation with clinical outcomes to EGFR-TKIsZhiyong Liang, Ying Cheng, Yuan Chen, et al.Journal of Natural Products|February 16, 2022
Angiogenesis-Inhibitory Piperidine Alkaloids from the Leaves of <i>Microcos paniculata</i>Zhen-Long Wu, Wei-Yan Zhang, Jin-Cheng Zhong, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 17, 2018
Final Overall Survival Analysis From a Study Comparing First-Line Crizotinib Versus Chemotherapy in ALK-Mutation-Positive Non-Small-Cell Lung CancerBenjamin J Solomon, Dong-Wan Kim, Yi-Long Wu, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 3, 2022
Adebrelimab (SHR-1316) in Combination With Chemotherapy as Perioperative Treatment in Patients With Resectable Stage II to III NSCLCs: An Open-Label, Multicenter, Phase 1b TrialWanpu Yan, Wen-Zhao Zhong, Yan-Hui Liu, et al.Clinical Lung Cancer|July 28, 2016
Soluble c-Met Levels Correlated With Tissue c-Met Protein Expression in Patients With Advanced Non-Small-Cell Lung CancerHong-Fei Gao, An-Na Li, Jin-Ji Yang, et al.Bioorganic & Medicinal Chemistry Letters|December 28, 2010
Discovery of a series of potent arylthiadiazole H(3) antagonistsDong Xiao, Anandan Palani, Michael Sofolarides, et al.Cancer Research and Treatment|July 14, 2017
Crizotinib versus Chemotherapy in Asian Patients with ALK-Positive Advanced Non-small Cell Lung CancerMakoto Nishio, Dong-Wan Kim, Yi-Long Wu, et al.Pageof 224